Department of Surgery, University Malaya Medical Centre, Kuala Lumpur, Malaysia.
Singapore Med J. 2021 Dec;62(12):636-641. doi: 10.11622/smedj.2021051. Epub 2021 May 19.
This study aimed to investigate the clinicopathological patterns and survival outcomes of patients with young-onset colorectal cancer (CRC) in Malaysia.
A total of 206 patients with young-onset CRC (age < 50 years at diagnosis) and 1,715 patients with late-onset CRC (age ≥ 50 years at diagnosis) diagnosed during 2002-2016 were included. The clinicopathological characteristics of patients with young-onset CRC were compared with those of patients with late-onset CRC during 2009-2013. Kaplan-Meier survival analysis was performed to determine the overall survival (OS) and disease-specific survival (DSS) in these patients.
The overall proportion of young-onset CRC was 10.7%. The mean age for young-onset CRC was 39.5 ± 7.4 years, with a male-to-female ratio of 1.2:1. There were more Malay patients with young-onset CRC than late-onset CRC (44.0% vs. 19.9%, p = 0.004). Most CRCs were diagnosed at an advanced stage in both groups. However, young-onset CRC showed more aggressive tumour characteristics, such as poorer differentiation and mucinous subtype. Despite such differences, the OS and DSS in both groups were similar (five-year OS for young-onset CRC vs. late-onset CRC: 44.2% vs. 49.0%, p = 0.40; five-year DSS for young-onset CRC vs. late-onset CRC: 48.8% vs. 57.6%, p = 0.53; mean survival of young-onset CRC vs. late-onset CRC: 4.9 years vs. 5.4 years, p = 0.15). Advanced stage at diagnosis and the treatment modality used were independent prognostic factors.
The unique ethnic and histological differences between patients with young- and late-onset CRC suggest that young-onset CRC may represent a distinct entity. However, despite such differences, both groups were equivalent.
本研究旨在探讨马来西亚年轻型结直肠癌(CRC)患者的临床病理模式和生存结局。
共纳入 206 例年轻型 CRC(诊断时年龄<50 岁)和 1715 例晚发型 CRC(诊断时年龄≥50 岁)患者,这些患者均于 2002-2016 年期间确诊。比较了 2009-2013 年期间年轻型 CRC 患者与晚发型 CRC 患者的临床病理特征。采用 Kaplan-Meier 生存分析法确定这些患者的总生存(OS)和疾病特异性生存(DSS)。
年轻型 CRC 的总体比例为 10.7%。年轻型 CRC 的平均年龄为 39.5±7.4 岁,男女比例为 1.2:1。年轻型 CRC 患者中马来人多于晚发型 CRC(44.0% vs. 19.9%,p=0.004)。两组 CRC 均多处于晚期诊断。然而,年轻型 CRC 显示出更具侵袭性的肿瘤特征,如分化较差和黏液型。尽管存在这些差异,但两组的 OS 和 DSS 相似(年轻型 CRC 与晚发型 CRC 的五年 OS:44.2% vs. 49.0%,p=0.40;五年 DSS:48.8% vs. 57.6%,p=0.53;年轻型 CRC 与晚发型 CRC 的平均生存:4.9 年 vs. 5.4 年,p=0.15)。诊断时的晚期分期和所采用的治疗方式是独立的预后因素。
年轻型和晚发型 CRC 患者之间存在独特的种族和组织学差异,这表明年轻型 CRC 可能代表一种独特的实体。然而,尽管存在这些差异,两组的生存结局并无差异。